Literature DB >> 11485416

High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization.

B Bajaj1, P Lei, S T Andreadis.   

Abstract

We used a combination of mathematical modeling and experiments to investigate the rate-limiting steps of retroviral transduction on surface-bound fibronectin (FN) and identify the conditions that maximize the efficiency of gene transfer. Our results show that fibronectin-assisted gene transfer (FAGT) is a strong function of the time and temperature of virus incubation in FN-coated plates. Gene transfer increases sharply at short times, reaches a maximum at intermediate times, and eventually declines as a result of loss of retroviral activity. The maximum transduction efficiency and the time at which this is attained increase with decreasing temperature of virus incubation. Depending on the temperature and the type of target cells, the initial rate of gene transfer increases by 3- to 10-fold and the maximum transduction efficiency increases by 2- to 4-fold as compared to traditional transduction (TT). Interestingly, Polybrene (PB) inhibits FAGT in a dose-dependent manner by inhibiting binding of retrovirus to FN. In contrast to traditional transduction, FAGT yields higher than 10-fold transduction efficiencies with concentrated retrovirus stocks. Gene transfer is directly proportional to the concentration of the virus-containing medium with no sign of saturation for the range of concentrations tested. These results suggest that immobilization of recombinant retrovirus can be rationally optimized to yield high efficiency of gene transfer to primary cells and improve the prospect of gene therapy for the treatment of human disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485416     DOI: 10.1021/bp010039n

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  24 in total

Review 1.  Gene therapy for urologic cancer.

Authors:  Fernando A Ferrer; Ronald Rodriguez
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 3.092

Review 2.  Design of modular non-viral gene therapy vectors.

Authors:  Laura De Laporte; Jennifer Cruz Rea; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

Review 3.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

4.  Gene Delivery by Immobilization to Cell-Adhesive Substrates.

Authors:  Zain Bengali; Lonnie D Shea
Journal:  MRS Bull       Date:  2005-09-05       Impact factor: 6.578

Review 5.  Engineering biomaterial systems to enhance viral vector gene delivery.

Authors:  Jae-Hyung Jang; David V Schaffer; Lonnie D Shea
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

6.  Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion.

Authors:  Jeffrey R Brender; Kevin Hartman; Lindsey M Gottler; Marchello E Cavitt; Daniel W Youngstrom; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

7.  NANOG Restores Contractility of Mesenchymal Stem Cell-Based Senescent Microtissues.

Authors:  Aref Shahini; Panagiotis Mistriotis; Mohammadnabi Asmani; Ruogang Zhao; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

8.  Primary attachment of murine leukaemia virus vector mediated by particle-associated heparan sulfate proteoglycan.

Authors:  Nina Kureishy; Daisy Faruque; Colin D Porter
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

9.  Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin.

Authors:  Pedro Lei; Bharat Bajaj; Stelios T Andreadis
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.

Authors:  Laura De Laporte; Anna Lei Yan; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-01-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.